Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
1.
Zhonghua Yu Fang Yi Xue Za Zhi ; 56(9): 1203-1210, 2022 Sep 06.
Artigo em Chinês | MEDLINE | ID: mdl-36207881

RESUMO

Disorders of sex development (DSD) is a class of diseases characterized by discordant phenotypes of sex chromosome karyotypes, gonads and external genitalia. The etiology is complex and the clinical manifestations are varied. Understanding the clinical characteristics of patients with various types of DSD help make accurate etiological diagnosis and prepare individualized treatment plans according to the etiology (including sex assignment, endocrine hormone replacement, surgery and fertility protection, etc.). Due to the increased risk of DSD in the second pregnancy of the parents of DSD patients, early preventive measures such as pre-pregnancy genetic counseling and prenatal diagnosis during pregnancy can effectively avoid or reduce the risk of DSD in their siblings.


Assuntos
Transtornos do Desenvolvimento Sexual , Transtornos do Desenvolvimento Sexual/diagnóstico , Transtornos do Desenvolvimento Sexual/genética , Transtornos do Desenvolvimento Sexual/prevenção & controle , Feminino , Hormônios , Humanos , Gravidez , Irmãos
2.
Endocrinol Metab Clin North Am ; 45(2): 267-81, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-27241964

RESUMO

Congenital adrenal hyperplasia (CAH) owing to 21-hydroxylase deficiency is a monogenic disorder of adrenal steroidogenesis. To prevent genital ambiguity, in girls, prenatal dexamethasone treatment is administered early in the first trimester. Prenatal genetic diagnosis of CAH and fetal sex determination identify affected female fetuses at risk for genital virilization. Advancements in prenatal diagnosis are owing to improved understanding of the genetic basis of CAH and improved technology. Cloning of the CYP21A2 gene ushered in molecular genetic analysis as the current standard of care. Noninvasive prenatal diagnosis allows for targeted treatment and avoids unnecessary treatment of males and unaffected females.


Assuntos
Hiperplasia Suprarrenal Congênita/diagnóstico , Diagnóstico Pré-Natal , Dexametasona/uso terapêutico , Transtornos do Desenvolvimento Sexual/prevenção & controle , Feminino , Humanos , Masculino , Gravidez
5.
J Pediatr Endocrinol Metab ; 26(9-10): 949-53, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23729539

RESUMO

We report an 18-year-old Japanese male with a lack of secondary sex characterization and growth failure caused by a rare association between Rathke's cyst and hypophysitis. He was referred to us because of delayed secondary sex characterization. Endocrinological examination showed panhypopituitarism, and the replacement of hydrocortisone, levothyroxine, and desmopressin acetate (DDAVP) was initiated. Brain magnetic resonance imaging (MRI) showed a suprasellar region and a swollen pituitary stalk. The mass was partially resected using the transsphenoidal approach. The pathological diagnosis was hypophysitis and Rathke's cyst. Follow-up MRI performed 1 year after surgery showed that the size of sellar region had not changed. After surgery, in addition to pre-operative hormonal replacement, growth hormone and testosterone were initiated. Two years later, the size of sellar region remains unchanged. In conclusion, while an association between Rathke's cyst and hypophysitis is rare, we suggest that this condition should be included in differential diagnosis of the sellar region, even in adolescents.


Assuntos
Cistos do Sistema Nervoso Central/complicações , Transtornos do Desenvolvimento Sexual/etiologia , Transtornos do Crescimento/etiologia , Hipopituitarismo/complicações , Hipófise/imunologia , Neoplasias Hipofisárias/complicações , Adolescente , Desenvolvimento do Adolescente/efeitos dos fármacos , Cistos do Sistema Nervoso Central/fisiopatologia , Cistos do Sistema Nervoso Central/cirurgia , Transtornos do Desenvolvimento Sexual/prevenção & controle , Transtornos do Crescimento/prevenção & controle , Terapia de Reposição Hormonal , Hormônio do Crescimento Humano/uso terapêutico , Humanos , Hipopituitarismo/tratamento farmacológico , Hipopituitarismo/imunologia , Hipopituitarismo/fisiopatologia , Masculino , Tamanho do Órgão/efeitos dos fármacos , Hipófise/patologia , Hipófise/fisiopatologia , Hipófise/cirurgia , Neoplasias Hipofisárias/fisiopatologia , Neoplasias Hipofisárias/cirurgia , Testosterona/uso terapêutico , Resultado do Tratamento
9.
J Nutr Sci Vitaminol (Tokyo) ; 57(5): 333-9, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22293210

RESUMO

The purpose of this study was to clarify the effects of nutrients on the gonadal development of male rats kept under constant darkness as a model of disturbed daily rhythm. In the present study we examined fat-soluble vitamins and their interactions in this test population. Four fat-soluble vitamins (vitamin A (V.A), vitamin D (V.D), vitamin E (V.E) and vitamin K (V.K)) were selected as experimental factors, and the dietary content of these vitamins was normal (AIN-93G) or three times the normal content. Lighting conditions (constant darkness or normal lighting) were also added as a factor. Four-week-old rats (Fischer 344 strain) were kept under constant darkness or normal lighting (12-h light/dark cycle) for 4 wk. The lighting condition and V.E, and the interactions between the lighting condition and V.E and between V.A and V.D were observed to affect the testes and epididymides weights. There was an influence of the lighting condition only on the seminal vesicles and prostate weights and the serum testosterone concentration. Among the constant darkness groups (D-groups), the highest value for testes weight was observed under the normal-V.A, normal-V.D and high-V.E diet. The interaction between lighting condition and V.E showed the testes weight increased slightly in response to changing to a high-V.E diet from a normal-V.E diet under normal lighting (N-group) but was greatly increased in response to this change in the D-group. It became clear that the amount of dietary V.E necessary for the gonadal development of rats increases when rats are kept under constant darkness.


Assuntos
Transtornos Cronobiológicos/fisiopatologia , Transtornos do Desenvolvimento Sexual/prevenção & controle , Genitália Masculina/patologia , Vitamina A/uso terapêutico , Vitamina D/uso terapêutico , Vitamina E/uso terapêutico , Animais , Suplementos Nutricionais , Transtornos do Desenvolvimento Sexual/etiologia , Transtornos do Desenvolvimento Sexual/metabolismo , Transtornos do Desenvolvimento Sexual/patologia , Ingestão de Energia , Epididimo/patologia , Masculino , Tamanho do Órgão , Fotoperíodo , Próstata/patologia , Ratos , Ratos Endogâmicos F344 , Glândulas Seminais/patologia , Testículo/crescimento & desenvolvimento , Testosterona/sangue , Vitamina K/uso terapêutico
11.
Am J Bioeth ; 10(9): 35-45, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20818559

RESUMO

On February 3, 2010, a "Letter of Concern from Bioethicists," organized by fetaldex.org, was sent to report suspected violations of the ethics of human subjects research in the off-label use of dexamethasone during pregnancy by Dr. Maria New. Copies of this letter were submitted to the FDA Office of Pediatric Therapeutics, the Department of Health and Human Services (DHHS) Office for Human Research Protections, and three universities where Dr. New has held or holds appointments. We provide a critical appraisal of the Letter of Concern and show that it makes false claims, misrepresents scientific publications and websites, fails to meet standards of evidence-based reasoning, makes undocumented claims, treats as settled matters what are, instead, ongoing controversies, offers "mere opinion" as a substitute for argument, and makes contradictory claims. The Letter of Concern is a case study in unethical transgressive bioethics. We call on fetaldex.org to withdraw the letter and for co-signatories to withdraw their approval of it.


Assuntos
Hiperplasia Suprarrenal Congênita/diagnóstico , Hiperplasia Suprarrenal Congênita/tratamento farmacológico , Correspondência como Assunto , Dexametasona/administração & dosagem , Transtornos do Desenvolvimento Sexual/prevenção & controle , Eticistas/normas , Doenças Fetais/tratamento farmacológico , Genitália Feminina/anormalidades , Uso Off-Label , Diagnóstico Pré-Natal , Experimentação Humana Terapêutica/ética , Hiperplasia Suprarrenal Congênita/complicações , Hiperplasia Suprarrenal Congênita/enzimologia , Ensaios Clínicos como Assunto , Transtornos do Desenvolvimento Sexual/etiologia , Esquema de Medicação , Comitês de Ética em Pesquisa , Feminino , Doenças Fetais/diagnóstico , Doenças Fetais/enzimologia , Genitália Feminina/cirurgia , Glucocorticoides/administração & dosagem , Humanos , Consentimento Livre e Esclarecido/ética , Masculino , Uso Off-Label/ética , Gravidez , Procedimentos de Cirurgia Plástica , Encaminhamento e Consulta , Esteroide 21-Hidroxilase/metabolismo , Estados Unidos , United States Food and Drug Administration , Virilismo/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...